Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MABTHERA 10MG-1ML CONC. FOR I.V INFUSION - SFDA Drug Approval Details

Approvals/SFDA/MABTHERA 10MG-1ML CONC. FOR I.V INFUSION

Authorized

STANDARD

MABTHERA 10MG-1ML CONC. FOR I.V INFUSION

Unknown🇸🇦 Saudi Food and Drug Authority

Approval Date: N/A
Approval ID: 77fbab23ddc8a613
Company: Unknown
Type: Standard

Approval Details

Approval Id: 77fbab23ddc8a613
Drug Approval Sfda Name: MABTHERA 10MG-1ML CONC. FOR I.V INFUSION
Trade Name: MABTHERA 10MG-1ML CONC. FOR I.V INFUSION
Generic Name: RITUXIMAB
Register Number: 1311258586
Route Of Administration: Intravenous use
Package Type: Vial
Package Size: 2
Size: 10
Size Unit: ml
Legal Status: Prescription
Authorization Status: Valid
Marketing Status: Marketed
Product Control: Uncontrolled
Storage Conditions: store in a refrigerator (2°c – 8°c)
Shelf Life: 36 Months
Distribution Site: Hospital
Description Code: 7000001111-10-100000073987
Price: 1914.7

Active Ingredients

Authorized

Quick Info

Agency

SFDA

Country

🇸🇦

Approval ID

77fbab23ddc8a613

Type

Standard

Back to SFDA Approvals